| Treyton Oak Towers | |
| 211 West Oak Street, Louisville, Kentucky 40203 | |
| (502) 589-3211 | |
| Name | Treyton Oak Towers |
|---|---|
| Location | 211 West Oak Street, Louisville, Kentucky |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 60 |
| Occupancy Rate | 65.83% |
| Medicare ID (CCN) | 185175 |
| Legal Business Name | Third And Oak Corporation |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1649261314 |
| Organization Name | THIRD AND OAK CORPORATION |
| Doing Business As | TREYTON OAK TOWERS |
| Address | 211 West Oak Street, Treyton Oak Towers, Louisville, KY 40203 |
| Phone Number | 502-589-3211 |
News Archive
Astute Medical, Inc., a developer of novel, biomarker-based medical diagnostics, today announced completion of a $26.5 million series B financing co-led by Domain Associates and Delphi Ventures. Astute will use the funding to advance research and development aimed at the identification and validation of protein biomarkers with the goal of commercializing high potential diagnostic products.
Healthcare consumers, benefits managers, and even government officials are using the internet to buy unapproved prescription drugs illegally, according to a report to be published in the International Journal of Electronic Healthcare.
Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) to market Tamiflu (oseltamivir phosphate) capsules in pediatric doses of 30 mg and 45 mg.
GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to support the research of a new approach to treating metastatic cancer. Under this grant, valued at over $300,000, GenVec will investigate the hypothesis that the delivery of a specific gene will stimulate an antitumor response that could control cancer metastases.
Australia could save billions of dollars in healthcare costs by investing in proven treatments for people with diabetic foot disease, according to QUT research.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Astute Medical, Inc., a developer of novel, biomarker-based medical diagnostics, today announced completion of a $26.5 million series B financing co-led by Domain Associates and Delphi Ventures. Astute will use the funding to advance research and development aimed at the identification and validation of protein biomarkers with the goal of commercializing high potential diagnostic products.
Healthcare consumers, benefits managers, and even government officials are using the internet to buy unapproved prescription drugs illegally, according to a report to be published in the International Journal of Electronic Healthcare.
Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) to market Tamiflu (oseltamivir phosphate) capsules in pediatric doses of 30 mg and 45 mg.
GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to support the research of a new approach to treating metastatic cancer. Under this grant, valued at over $300,000, GenVec will investigate the hypothesis that the delivery of a specific gene will stimulate an antitumor response that could control cancer metastases.
Australia could save billions of dollars in healthcare costs by investing in proven treatments for people with diabetic foot disease, according to QUT research.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $11278 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 12.36 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.6 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 75 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.52 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 4.63 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.85 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 7.77 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.94 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.35 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 21.1 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.78 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.76 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 83.23 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.38 | 82.93 |
News Archive
Astute Medical, Inc., a developer of novel, biomarker-based medical diagnostics, today announced completion of a $26.5 million series B financing co-led by Domain Associates and Delphi Ventures. Astute will use the funding to advance research and development aimed at the identification and validation of protein biomarkers with the goal of commercializing high potential diagnostic products.
Healthcare consumers, benefits managers, and even government officials are using the internet to buy unapproved prescription drugs illegally, according to a report to be published in the International Journal of Electronic Healthcare.
Roche has filed a supplemental new drug application (sNDA) with the U.S. Food and Drug Administration (FDA) to market Tamiflu (oseltamivir phosphate) capsules in pediatric doses of 30 mg and 45 mg.
GenVec, Inc. announced today that it has received a Phase I Small Business Innovation and Research (SBIR) grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to support the research of a new approach to treating metastatic cancer. Under this grant, valued at over $300,000, GenVec will investigate the hypothesis that the delivery of a specific gene will stimulate an antitumor response that could control cancer metastases.
Australia could save billions of dollars in healthcare costs by investing in proven treatments for people with diabetic foot disease, according to QUT research.
› Verified 9 days ago
Christian Health Center Location: 920 South Fourth Street, Louisville, Kentucky 40203 Phone: (502) 583-6533 | |
Highlands Nursing And Rehabilitation Location: 1705 Stevens Avenue, Louisville, Kentucky 40205 Phone: (502) 451-7330 | |
Hillcreek Rehab And Care, Llc Location: 3116 Breckenridge Lane, Louisville, Kentucky 40220 Phone: (502) 459-9120 | |
Landmark Of Iroquois Park Rehab And Nursing Center Location: 900 Gagel Avenue, Louisville, Kentucky 40216 Phone: (502) 368-5827 | |
Landmark Of Louisville Rehabilitation And Nursing Location: 1155 Eastern Parkway, Louisville, Kentucky 40217 Phone: (502) 636-5241 | |
Franciscan Health Care Center Location: 3625 Fern Valley Road, Louisville, Kentucky 40219 Phone: (502) 964-3381 |